BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Treatment
38 results:

  • 1. Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma.
    Liang J; Bi G; Sui Q; Zhao G; Zhang H; Bian Y; Chen Z; Huang Y; Xi J; Shi Y; Wang Q; Zhan C
    Cell Rep; 2024 Feb; 43(2):113771. PubMed ID: 38335093
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC).
    Mukherjee O; Paul S; Das S; Rakshit S; Shanmugam G; George M; Sarkar K
    Pathol Res Pract; 2024 Jan; 253():155004. PubMed ID: 38086291
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SOCS2 inhibits hepatoblastoma metastasis via downregulation of the JAK2/stat5 signal pathway.
    Lv Y; Xie X; Zou G; Kong M; Yang J; Chen J; Xiang B
    Sci Rep; 2023 Dec; 13(1):21814. PubMed ID: 38071211
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. lung cancer treatment potential and limits associated with the STAT family of transcription factors.
    Faida P; Attiogbe MKI; Majeed U; Zhao J; Qu L; Fan D
    Cell Signal; 2023 Sep; 109():110797. PubMed ID: 37423343
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prolactin is Expressed in Uterine Leiomyomas and Promotes Signaling and Fibrosis in Myometrial Cells.
    DiMauro A; Seger C; Minor B; Amitrano AM; Okeke I; Taya M; Rackow AR; Kumar D; Kottman RM; Bhagavath B; Hammes SR
    Reprod Sci; 2022 Sep; 29(9):2525-2535. PubMed ID: 34724171
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell lung cancer (NSCLC) Cells.
    Rugamba A; Kang DY; Sp N; Jo ES; Lee JM; Bae SW; Jang KJ
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209829
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation.
    Li Y; Li Y; Zhang H; Shi R; Zhang Z; Liu H; Chen J
    BMC Pulm Med; 2021 Jun; 21(1):190. PubMed ID: 34090412
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/stat5 pathway in tumor microenvironment.
    Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
    Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis.
    Qin FL; Xu ZY; Yuan LQ; Chen WJ; Wei JB; Sun Y; Li SK
    FEBS Open Bio; 2020 Sep; 10(9):1921-1933. PubMed ID: 32686362
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of an AP1-ZFP36 Regulatory Network Associated with Breast cancer Prognosis.
    Canzoneri R; Naipauer J; Stedile M; Rodriguez Peña A; Lacunza E; Gandini NA; Curino AC; Facchinetti MM; Coso OA; Kordon E; Abba MC
    J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):163-172. PubMed ID: 32248342
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Suppressing stat5 signaling affects osteosarcoma growth and stemness.
    Subramaniam D; Angulo P; Ponnurangam S; Dandawate P; Ramamoorthy P; Srinivasan P; Iwakuma T; Weir SJ; Chastain K; Anant S
    Cell Death Dis; 2020 Feb; 11(2):149. PubMed ID: 32094348
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis.
    Wang H; Liu Z; Guan L; Li J; Chen S; Yu W; Lai M
    Pharmacol Res; 2020 Mar; 153():104661. PubMed ID: 31982491
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IL-17
    Lückel C; Picard F; Raifer H; Campos Carrascosa L; Guralnik A; Zhang Y; Klein M; Bittner S; Steffen F; Moos S; Marini F; Gloury R; Kurschus FC; Chao YY; Bertrams W; Sexl V; Schmeck B; Bonetti L; Grusdat M; Lohoff M; Zielinski CE; Zipp F; Kallies A; Brenner D; Berger M; Bopp T; Tackenberg B; Huber M
    Nat Commun; 2019 Dec; 10(1):5722. PubMed ID: 31844089
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy.
    Shaw V; Srivastava S; Srivastava SK
    Semin Cancer Biol; 2021 Jan; 68():75-83. PubMed ID: 31618686
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. IL-7-Mediated IL-7R-JAK3/stat5 signalling pathway contributes to chemotherapeutic sensitivity in non-small-cell lung cancer.
    Shi L; Xu Z; Yang Q; Huang Y; Gong Y; Wang F; Ke B
    Cell Prolif; 2019 Nov; 52(6):e12699. PubMed ID: 31599032
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Antitumor Activity of a Novel Tyrosine Kinase Inhibitor AIU2001 Due to Abrogation of the DNA Damage Repair in Non-Small Cell lung cancer Cells.
    Ryu H; Choi HK; Kim HJ; Kim AY; Song JY; Hwang SG; Kim JS; Kim DU; Kim EH; Kim J; Ahn J
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554189
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated stat5 pathway.
    Lee YS; Kim KC; Mongre RK; Kim JY; Kim YR; Choi DY; Song S; Yun J; Han SB; Yoon DY; Hong JT
    Cell Death Dis; 2019 Jul; 10(7):506. PubMed ID: 31263095
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma.
    Elmaci I; Altinoz MA
    Crit Rev Oncol Hematol; 2018 Aug; 128():96-109. PubMed ID: 29958636
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer.
    Bruno A; Bassani B; D'Urso DG; Pitaku I; Cassinotti E; Pelosi G; Boni L; Dominioni L; Noonan DM; Mortara L; Albini A
    FASEB J; 2018 Oct; 32(10):5365-5377. PubMed ID: 29763380
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and lung cancer Cells.
    Merkle R; Steiert B; Salopiata F; Depner S; Raue A; Iwamoto N; Schelker M; Hass H; Wäsch M; Böhm ME; Mücke O; Lipka DB; Plass C; Lehmann WD; Kreutz C; Timmer J; Schilling M; Klingmüller U
    PLoS Comput Biol; 2016 Aug; 12(8):e1005049. PubMed ID: 27494133
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.